KLSE (MYR): SUNZEN (0148)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.35
Today's Change
+0.005 (1.45%)
Day's Change
0.345 - 0.35
Trading Volume
1,000,000
Market Cap
255 Million
NOSH
730 Million
Latest Quarter
31-Mar-2024 [#0]
Announcement Date
24-May-2024
Next Quarter
30-Jun-2024
Est. Ann. Date
30-Aug-2024
Est. Ann. Due Date
29-Aug-2024
QoQ | YoY
-36.62% | 83.52%
Revenue | NP to SH
99,053.000 | 7,695.000
RPS | P/RPS
13.57 Cent | 2.58
EPS | P/E | EY
1.05 Cent | 33.19 | 3.01%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.18 | 1.91
QoQ | YoY
13.2% | 93.88%
NP Margin | ROE
9.03% | 5.75%
F.Y. | Ann. Date
31-Mar-2024 | 24-May-2024
Latest Audited Result
31-Dec-2022
Announcement Date
26-Apr-2023
Next Audited Result
31-Dec-2023
Est. Ann. Date
26-Apr-2024
Est. Ann. Due Date
28-Jun-2024
Revenue | NP to SH
97,103.000 | 3,636.000
RPS | P/RPS
13.31 Cent | 2.63
EPS | P/E | EY
0.50 Cent | 70.24 | 1.42%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.16 | 2.12
YoY
420.92%
NP Margin | ROE
4.79% | 3.02%
F.Y. | Ann. Date
31-Dec-2022 | 23-Feb-2023
Revenue | NP to SH
104,646.857 | 7,516.285
RPS | P/RPS
14.34 Cent | 2.44
EPS | P/E | EY
1.03 Cent | 33.98 | 2.94%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
1.35% | 74.96%
NP Margin | ROE
8.35% | 5.61%
F.Y. | Ann. Date
31-Mar-2024 | 24-May-2024
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Profit Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted EPS Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Dividend Years | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Average ROE | 1.49% | 1.17% | ||
Average Net Profit Margin | 8.70% | 6.94% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Total Positive Profit Years | 2 / 5 | 40.00% | 5 / 10 | 50.00% |
Continuous Quarters Of Positive Profit | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Continuous Quarters Of Profit Growth | 3 / 5 | 60.00% | 3 / 10 | 30.00% |
Continuous Quarters Of Adjusted EPS Growth | 3 / 5 | 60.00% | 3 / 10 | 30.00% |
Total Dividend Years | 0 / 5 | 0.00% | 2 / 10 | 20.00% |
Continuous Quarters Of Dividend | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Average ROE | -7.44% | -2.17% | ||
Average Net Profit Margin | -3.81% | -0.67% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 99,053 | 104,646 | 97,103 | 126,042 | 162,014 |
NP to SH | 7,695 | 7,516 | 3,636 | -2,562 | -6,645 |
Dividend | 0 | 0 | 0 | 263 | 0 |
Adjusted EPS | 1.05 | 1.03 | 0.50 | -0.35 | -0.92 |
Adjusted DPS | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | -18.34% | 4.01% | 430.01% | -3.25% | 0.47% |
NP to Owner | -36.62% | 83.52% | 716.48% | 2.46% | 35.19% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | -36.62% | 83.52% | 716.48% | 2.46% | 35.19% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 2.01% | -38.86% | -21.41% | 7.77% | -35.41% | -16.97% | 7.36% | -40.07% | -22.96% |
NP to Owner | 111.63% | 215.79% | 400.32% | 106.72% | 213.11% | 393.34% | 420.92% | 154.71% | 241.90% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | 111.63% | 215.79% | 400.32% | 106.72% | 213.11% | 393.34% | 420.92% | 154.71% | 241.90% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
start making profit finally after few years..improved eps,year on year grow,ebit, and good balance sheet.i like it,so i am in..cheers!!
1 month ago
i am out.. till i can see how the rising diesel price will effect its revenue in nextQ.
sayang meehhh..this counter have full of potential..
1 month ago
SUNZEN participates in a reality show, is another merger and acquisition coming? 😃
https://www.chinapress.com.my/20240710/%E5%85%A8%E9%A9%AC%E9%A6%96%E4%B8%AA%E5%B9%B6%E8%B4%AD%E7%9C%9F%E4%BA%BA%E7%A7%80-%E5%8A%A9%E4%B8%AD%E5%B0%8F%E4%BC%81%E4%B8%9A%E6%8B%93%E5%B1%95%E4%B8%9A%E5%8A%A1/
1 week ago
The director is buying a lot of shares. Sun Zhen has woken up
https://klse.i3investor.com/web/insider/detail/D_179805_103105651
1 week ago
Feel free to check this out: https://klse.i3investor.com/web/blog/detail/HealthBusiness/2024-07-15-story-h-156958915-A_New_Additional_Into_My_Portfolio_Sunzen_Biotech_s_Transformation_and_
Let you briefly understand the company's situation 🙂
1 week ago
A hidden dragon in Bursa. Look at its 1Y - 5Y price movement, it moves like YTL Power !
6 days ago
one of the hidden gem... after acquiring YANMING、FINSOURCE & ECOLITE, Sunzen performance are improving so much
6 days ago
performance not bad, steadily growing for few years.. might be the potential break out stock in 2024
6 days ago
Great move for exiting animal health business, now company have a better growth & direction now
5 days ago
Sunzen is committed to building an ecosystem that integrates human healthcare and financial services now. Bright future ahead
5 days ago
Over the last three years, Sunzen has grown earnings per share (EPS) at as impressive rate. It will attract more investors for sure
3 days ago
Share price retreats slight today due to exercise of warrants. https://klse.i3investor.com/web/mktbzz/additional-detail/37898_2565516449
3 days ago
Very strong at 35, Strong growth every quarter... looking forward to Sunzen future prospect...
2 hours ago
Sunzen has more than 20 years of experience in managing a realm of businesses that includes fast-moving consumer goods, animal health products, financial solutions, food processing research and development, and raw materials export. Bright future ahead
1 hour ago
LuckyWinForever
Chance for me to enter is coming...🤗
2023-11-09 10:23